What is the recommended heparin (unfractionated heparin) bolus and hourly dose for dialysis patients?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 6, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Heparin Dosing for Hemodialysis Patients

For dialysis patients, the recommended unfractionated heparin regimen is a bolus of 25-30 units/kg followed by an infusion rate of 1,500-2,000 units/hour, adjusted based on coagulation parameters. 1

Initial Dosing Protocol

Bolus Dose

  • Administer 25-30 units/kg as an initial IV bolus at the start of dialysis 1
  • For a 70kg patient, this would be approximately 1,750-2,100 units

Maintenance Infusion

  • Follow with a continuous infusion of 1,500-2,000 units/hour 1
  • Continue infusion until approximately 30 minutes before the end of the dialysis session to reduce post-procedure bleeding risk 2

Monitoring and Adjustment

  • Target an aPTT of 1.5-2.0 times normal (approximately 50-70 seconds) 1
  • Monitor aPTT at baseline and approximately every 4 hours during treatment 1
  • Anti-Xa levels of 0.3-0.7 IU/mL are considered sufficient for anticoagulation during dialysis 2
  • Visually inspect the dialyzer header and venous air detector chamber for clots to assess adequacy of anticoagulation 3

Alternative Dosing Methods

Bolus-Only Method

  • Some centers use a bolus-only approach with 3,000 units at the start of dialysis followed by 2,000 units two hours later 4
  • This method may provide more effective anticoagulation compared to continuous infusion in some patients 4

Continuous Infusion Without Bolus

  • Less commonly used but may be appropriate for patients at high bleeding risk 2
  • Typically requires higher total heparin doses to maintain adequate anticoagulation 3

Special Considerations

  • For patients at high bleeding risk, consider reducing the bolus to 15-20 units/kg and the infusion to 800-1,200 units/hour 5
  • Patients with renal failure may have altered heparin pharmacokinetics, with terminal half-life of approximately 54 minutes 2
  • Ensure adequate mixing of heparin with blood by administering the bolus a few minutes prior to connecting the patient to the circuit 3
  • Monitor for signs of heparin-induced thrombocytopenia by checking platelet counts regularly 1

Practical Implementation

  • Administer the bolus dose via the arterial line of the dialysis circuit 3
  • Prepare the maintenance infusion by diluting heparin in normal saline for consistent delivery 1
  • Stop the heparin infusion approximately 30-60 minutes before the end of dialysis to reduce post-procedure bleeding risk 2
  • Assess for adequate anticoagulation by checking for clots in the circuit and filter during dialysis 3

Remember that while these are standard recommendations, the optimal heparin regimen should be determined based on the patient's clinical status, bleeding risk, and response to therapy.

References

Research

Pharmacodynamics of unfractionated heparin during and after a hemodialysis session.

American journal of kidney diseases : the official journal of the National Kidney Foundation, 2008

Research

Optimization of heparin anticoagulation for hemodialysis.

Hemodialysis international. International Symposium on Home Hemodialysis, 2011

Research

Use of low-dose low molecular weight heparin in hemodialysis.

American journal of kidney diseases : the official journal of the National Kidney Foundation, 1996

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.